Verastem Inc (NASDAQ:VSTM)

2.61
Delayed Data
As of Oct 21
 -0.06 / -2.25%
Today’s Change
1.14
Today|||52-Week Range
4.93
+22.54%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$500.7M

Company Description

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Contact Information

Verastem, Inc.
117 Kendrick Street
Needham Massachusetts 02494
P:(781) 292-4200
Investor Relations:
(781) 469-1579

Employees

Shareholders

Other institutional44.49%
Mutual fund holders20.79%
Individual stakeholders18.72%

Top Executives

Brian M. StuglikChief Executive Officer & Director
Dan PatersonPresident & Chief Operating Officer
Robert E. GagnonChief Financial & Business Officer
Jonathan PachterChief Scientific Officer
Louis J. DenisChief Medical Officer